Biostat STR Generation 3

In this webinar, we will introduce two products that have joined Sartorius's single-use bioreactor portfolio. We will explain the scalable design of the Univessel SU 10 L, which is compliant with GMP manufacturing, and its three applications, as well as the enhanced oxygen transfer performance and culture productivity provided by the Flexsafe bag equipped with the Intensified Sparger. 【Key Learning Points】 ■ Overview of the scalable bioreactor portfolio ■ Overview and applications of the new product Univessel SU 10 L ■ Overview and applications of the new product Flexsafe bag with Intensified Sparger 【Seminar Details】 ▪ Date: September 15 (Tuesday) at 3:00 PM (approximately 30 minutes) ▪ Format: Webinar recorded broadcast If you are unable to attend on the day, please register anyway. A viewing URL will be sent to you later. *We apologize, but participation from other companies in the same industry and email addresses not associated with your organization is not permitted. Thank you for your understanding.

Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. As the number of pharmaceutical companies working on gene therapy and vaccines increases, the need for culture devices for microorganisms using single-use technology is becoming more and more critical. Sartorius has developed the Biostat STR MO to meet this demand. This webinar will introduce the features and application examples of Sartorius's first single-use culture device for microorganisms, the Biostat STR MO. [Seminar Overview] Date: May 18, 2023 (Thursday) from 3:00 PM (approximately 30 minutes) Webinar recorded broadcast [Japanese, free] We will send the recorded video and the download URL for related product materials to those who registered at a later date. *We apologize, but participation from other companies in the same industry and email addresses not affiliated with your organization is not permitted. Thank you for your understanding.

Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. The development of therapeutics using viral vectors is showing strong activity, with over 30% market growth expected in the next decade. The targets for treatment are diverse, but identifying critical process parameters through process development has become an urgent issue. As the first of two webinars, we will introduce the Ambr series, a representative of process development systems in upstream processes, as well as single-use bag bioreactors up to 2000L for large-scale manufacturing, including examples of associated PAT products. *We sincerely apologize, but participation from email addresses other than those of your company or organization is not permitted. Thank you for your understanding.

Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. Since 2020, Sartorius has been continuously working towards process enhancement, and in February, we introduced two bioreactors using single-use bags as the completed form of the enhanced upstream process. We will present the full details of the bioreactor system that meets the needs of commercial production and automation, along with case studies, in this webinar. Related site: https://srtrs.info/r/d7yvo